It’s an exciting time for Vermont’s bioscience leaders. There is a resurging statewide interest in bringing biopharmaceutical jobs, clinical trials and improved patient access to Vermont, and as America’s trade association representing innovative pharmaceutical companies, PhRMA is proud to join hands in this effort.
The biopharmaceutical industry’s statewide impact is impressive: there are more than 1,100 Vermont jobs that come directly from bioscience firms and research, and another 3,000 indirect jobs arise from the industry. Nearly 500 clinical trials conducted in the state study new treatments with 50 clinical trials still recruiting in locations such as Bennington, Colchester, Rutland, Burlington and White River Junction. Those trials and the local researchers conducting them couldn’t be done without the cooperation of Vermont research organizations like the University of Vermont College of Medicine and Vermont Cancer Center, among many others. Our collective and collaborative impact—on patients, local economy, and national innovation goals—is strong and growing.
Leaders like Vermont’s Senator Leahy have made it clear—the time for protecting innovation and life science patents is now. Vermont is in a unique collaborative position to work with other New England states to improve patient access and create new treatments, and PhRMA has long been a supporter of these goals. We applaud VBSA in their efforts to highlight new opportunities for action and research, and look forward to hearing their contribution to Vermont’s message of innovation.
Director, Communications and Public Affairs
Pharmaceutical Research and Manufacturers of America